Stereochemistry | ACHIRAL |
Molecular Formula | C19H42O3P2.C18H40O4P2.O2Tc |
Molecular Weight | 893.8429 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=[99Tc]=O.CCCCCP(CCOCC)CCP(CCOCC)CCOCC.CCOCCP(CCOCC)CCP(CCOCC)CCOCC
InChI
InChIKey=ZHNAJKOTNXMUGO-RCUQKECRSA-N
InChI=1S/C19H42O3P2.C18H40O4P2.2O.Tc/c1-5-9-10-14-23(15-11-20-6-2)18-19-24(16-12-21-7-3)17-13-22-8-4;1-5-19-9-13-23(14-10-20-6-2)17-18-24(15-11-21-7-3)16-12-22-8-4;;;/h5-19H2,1-4H3;5-18H2,1-4H3;;;/i;;;;1+1
Molybdenum-99 (99Mo, half-life = 66 h) is a parent radionuclide of a diagnostic nuclear isotope. It decays in technetium-99 m (half-life = 6 h), which is used in over 30 million procedures per year around the world. Between 95 and 98 percent of Mo-99 is currently being produced using highly enriched uranium (HEU) targets. Other medical isotopes such as iodine-131 (I-131) and xenon-133 (Xe-133) are by-products of the Mo-99 production process and will be sufficiently available if Mo-99 is available.